102 related articles for article (PubMed ID: 12737851)
1. Humanized docking system for assembly of targeting drug delivery complexes.
Backer MV; Gaynutdinov TI; Gorshkova II; Crouch RJ; Hu T; Aloise R; Arab M; Przekop K; Backer JM
J Control Release; 2003 May; 89(3):499-511. PubMed ID: 12737851
[TBL] [Abstract][Full Text] [Related]
2. Chimeric ribonuclease as a source of human adapter protein for targeted drug delivery.
Gaynutdinov TI; Myshkin E; Backer JM; Backer MV
Protein Eng; 2003 Oct; 16(10):771-5. PubMed ID: 14600207
[TBL] [Abstract][Full Text] [Related]
3. Adapter protein for site-specific conjugation of payloads for targeted drug delivery.
Backer MV; Gaynutdinov TI; Patel V; Jehning BT; Myshkin E; Backer JM
Bioconjug Chem; 2004; 15(5):1021-9. PubMed ID: 15366955
[TBL] [Abstract][Full Text] [Related]
4. Molecular vehicle for target-mediated delivery of therapeutics and diagnostics.
Gaidamakova EK; Backer MV; Backer JM
J Control Release; 2001 Jul; 74(1-3):341-7. PubMed ID: 11489516
[TBL] [Abstract][Full Text] [Related]
5. Assembly of targeting complexes driven by a single-chain antibody.
Backer MV; Elliot J; Gaynutdinov TI; Backer JM
J Immunol Methods; 2004 Jun; 289(1-2):37-45. PubMed ID: 15251410
[TBL] [Abstract][Full Text] [Related]
6. Self-assembled "dock and lock" system for linking payloads to targeting proteins.
Backer MV; Patel V; Jehning BT; Backer JM
Bioconjug Chem; 2006; 17(4):912-9. PubMed ID: 16848397
[TBL] [Abstract][Full Text] [Related]
7. Molecular vehicles for targeted drug delivery.
Backer MV; Aloise R; Przekop K; Stoletov K; Backer JM
Bioconjug Chem; 2002; 13(3):462-7. PubMed ID: 12009934
[TBL] [Abstract][Full Text] [Related]
8. Tumor imaging using a standardized radiolabeled adapter protein docked to vascular endothelial growth factor.
Blankenberg FG; Mandl S; Cao YA; O'Connell-Rodwell C; Contag C; Mari C; Gaynutdinov TI; Vanderheyden JL; Backer MV; Backer JM
J Nucl Med; 2004 Aug; 45(8):1373-80. PubMed ID: 15299064
[TBL] [Abstract][Full Text] [Related]
9. A "Dock and Lock" Approach to Preparation of Targeted Liposomes.
Backer MV; Backer JM
Methods Mol Biol; 2017; 1522():83-92. PubMed ID: 27837532
[TBL] [Abstract][Full Text] [Related]
10. Engineering S-protein fragments of bovine ribonuclease A for targeted drug delivery.
Backer MV; Gaynutdinov TI; Aloise R; Przekop K; Backer JM
Protein Expr Purif; 2002 Dec; 26(3):455-61. PubMed ID: 12460770
[TBL] [Abstract][Full Text] [Related]
11. A "dock and lock" approach to preparation of targeted liposomes.
Backer MV; Backer JM
Methods Mol Biol; 2010; 605():257-66. PubMed ID: 20072886
[TBL] [Abstract][Full Text] [Related]
12. Cysteine-containing fusion tag for site-specific conjugation of therapeutic and imaging agents to targeting proteins.
Backer MV; Levashova Z; Levenson R; Blankenberg FG; Backer JM
Methods Mol Biol; 2008; 494():275-94. PubMed ID: 18726580
[TBL] [Abstract][Full Text] [Related]
13. An interaction between S*tag and S*protein derived from human ribonuclease 1 allows site-specific conjugation of an enzyme to an antibody for targeted drug delivery.
Asai T; Wims LA; Morrison SL
J Immunol Methods; 2005 Apr; 299(1-2):63-76. PubMed ID: 15914191
[TBL] [Abstract][Full Text] [Related]
14. Efficient Intracellular Delivery of RNase A Using DNA Origami Carriers.
Zhao S; Duan F; Liu S; Wu T; Shang Y; Tian R; Liu J; Wang ZG; Jiang Q; Ding B
ACS Appl Mater Interfaces; 2019 Mar; 11(12):11112-11118. PubMed ID: 30874429
[TBL] [Abstract][Full Text] [Related]
15. CXCR4-targeted modular peptide carriers for efficient anti-VEGF siRNA delivery.
Egorova A; Shubina A; Sokolov D; Selkov S; Baranov V; Kiselev A
Int J Pharm; 2016 Dec; 515(1-2):431-440. PubMed ID: 27789364
[TBL] [Abstract][Full Text] [Related]
16. Preparation, structural analysis and bioactivity of ribonuclease A-albumin conjugate: tetra-conjugation or PEG as the linker.
Li C; Lin Q; Wang J; Shen L; Ma G; Su Z; Hu T
J Biotechnol; 2012 Dec; 162(2-3):283-8. PubMed ID: 23000658
[TBL] [Abstract][Full Text] [Related]
17. Human endothelial cells selectively express large amounts of pancreatic-type ribonuclease (RNase 1).
Landré JB; Hewett PW; Olivot JM; Friedl P; Ko Y; Sachinidis A; Moenner M
J Cell Biochem; 2002; 86(3):540-52. PubMed ID: 12210760
[TBL] [Abstract][Full Text] [Related]
18. Assembly of Protein-Polysaccharide Complexes for Delivery of Bioactive Ingredients: A Perspective Paper.
Wei Z; Huang Q
J Agric Food Chem; 2019 Feb; 67(5):1344-1352. PubMed ID: 30640454
[TBL] [Abstract][Full Text] [Related]
19. Intracellular delivery and anti-cancer effect of self-assembled heparin-Pluronic nanogels with RNase A.
Choi JH; Jang JY; Joung YK; Kwon MH; Park KD
J Control Release; 2010 Nov; 147(3):420-7. PubMed ID: 20688114
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cell growth by a fused protein of human ribonuclease 1 and human basic fibroblast growth factor.
Futami J; Seno M; Ueda M; Tada H; Yamada H
Protein Eng; 1999 Nov; 12(11):1013-9. PubMed ID: 10585508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
